Inclusion criteria:  All patients, whatever age or gender, clinically diagnosed with IRD or with high suspicion for IRDs based on clinical examination and functional tests (such as fundus exam and ERG), regardless of genetic testing Patients who attended a consultation at one of the participating centers from SENSGENE network over the inclusion period starting from sites initiation Patients who had been prescribed a genetic test for IRD prior to or at the date of inclusion.  Exclusion criteria:  Patients/Parents/Legally authorized representatives (LAR) opposed to the collection and processing of their medical data/the medical data of their children/the medical data of the person for whom they are LAR; Patients who are suffering from any other retinal disorder or optic neuropathy that may clinically or genetically overlap with IRD or non-genetic (phenocopy); Patients/parents/Legally authorized representatives (LAR) refusing genetic testing; Patients lacking decision-making capacity: Mental incapacity, unwillingness, or language barriers precluding adequate understanding or cooperation.